Genetic and epigenetic markers in colorectal cancer screening: recent advances (Q38676702)

5 September 2017

1 reference

title

Genetic and epigenetic markers in colorectal cancer screening: recent advances (English)

1 reference

colorectal cancer screening

5 September 2017

1 reference

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Manish Pratap Singh

1

1 reference

5 September 2017

Sandhya Rai

2

1 reference

5 September 2017

Shradha Suyal

3

1 reference

5 September 2017

Sunil Kumar Singh

4

1 reference

5 September 2017

Nand Kumar Singh

5

1 reference

5 September 2017

Akash Agarwal

6

1 reference

5 September 2017

Sameer Srivastava

7

1 reference

5 September 2017

language of work or name

1 reference

31 May 2017

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

5 September 2017

1 reference

5 September 2017

17

1 reference

5 September 2017

665-685

1 reference

5 September 2017

7

1 reference

A genetic model for colorectal tumorigenesis

5 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Biomarkers in Colorectal Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The chromosomal instability pathway in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Risk of cancer in cases of suspected lynch syndrome without germline mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Epigenetics and colorectal cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular phenotypes of colorectal cancer and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The consensus molecular subtypes of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Identification and characterization of the familial adenomatous polyposis coli gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The role of the Wnt signalling pathway in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Role of APC and DNA mismatch repair genes in the development of colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Colorectal cancer screening: prospects for molecular stool analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular stool screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Hereditary and familial colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Colorectal Cancer Biomarkers: Where Are We Now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Coexistent mutations of KRAS and PIK3CA affect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The colorectal adenoma-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Colorectal carcinogenesis: MSI-H versus MSI-L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA Methylation and Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Epigenetic biomarkers in colorectal cancer: premises and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular Features and Methylation Status in Early Onset (≤40 Years) Colorectal Cancer: A Population Based, Case-Control Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A two-gene blood test for methylated DNA sensitive for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Analysis of fecal DNA methylation to detect gastrointestinal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Detection of APC mutations in fecal DNA from patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Bioactive Nutrients and Nutrigenomics in Age-Related Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

New trends in molecular and cellular biomarker discovery for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA methylation differences associated with tumor tissues identified by genome scanning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Epigenetic inactivation of the extracellular matrix metallopeptidase ADAMTS19 gene and the metastatic spread in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

DNA methylation markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Epigenetics and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Global histone modification of histone H3 in colorectal cancer and its precursor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Recent approaches to identifying biomarkers for high-risk stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MiR-320e is a novel prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA profiling differentiates colorectal cancer according to KRAS status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Identification of a circulating microRNA signature for colorectal cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

The human gut microbiome as a screening tool for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Molecular markers for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2017.1337511

10.1080/14737159.2017.1337511

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference